NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins | NIH: National Institute of Allergy and Infectious Diseases
NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins | NIH: National Institute of Allergy and Infectious Diseases
A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun in Seattle.